Skip to main content
. 2024 Oct 3;56(10):2027–2035. doi: 10.1038/s41588-024-01913-5

Extended Data Fig. 10. Enrichment of coding and non-coding causal variants in druggable genes.

Extended Data Fig. 10

a, Enrichment of drug-target genes for fine-mapped genes with variants with high PPI for coding and non-coding variants. b, Enrichment of genes in protein-protein networks for genes with variants with high PPI for coding and non-coding variants. c, Enrichment of genes containing pathogenic variants in the ClinVar for fine-mapped genes with variants with high PPI for coding and non-coding variants. Error bars indicate the first and third quartiles. Annotated P-value was estimated comparing genes with the highest PPI > 10% to the highest PPI ≤ 10% by two-sided Fisher’s exact test (a,c) and Wilcoxon rank-sum test (b). The numbers of variants included in the analysis are shown after the PPI bins. PPI, posterior probability of inclusion.